By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Calcineurin inhibitor > Ciclosporin

Ciclosporin

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|607 words

Ciclosporin: A Powerful Immunosuppressive Drug

What is Ciclosporin?

Ciclosporin is a potent immunosuppressive medication belonging to a class of drugs called calcineurin inhibitors. Originally derived from a fungus, this medication is primarily used to prevent organ rejection in transplant patients and to treat certain autoimmune conditions. It works by selectively suppressing the immune system’s ability to attack transplanted organs or the body’s own tissues.

Uses

  • Organ transplant rejection prevention: The primary use is preventing rejection in kidney, liver, heart, and other organ transplants by suppressing the recipient’s immune response
  • Severe atopic dermatitis: Used topically for moderate to severe eczema when other treatments have failed, particularly in sensitive areas
  • Rheumatoid arthritis: Prescribed for severe cases that don’t respond adequately to other disease-modifying antirheumatic drugs
  • Psoriasis: Effective for severe plaque psoriasis when conventional treatments are inadequate or contraindicated
  • Nephrotic syndrome: Used to treat certain kidney disorders characterized by excessive protein loss in urine

How it works

Ciclosporin works by blocking calcineurin, an enzyme crucial for activating T-cells, which are key components of the immune system. By inhibiting this enzyme, the drug prevents T-cells from producing inflammatory substances called cytokines, effectively dampening the immune response. This selective immunosuppression helps prevent organ rejection and reduces inflammation in autoimmune conditions without completely shutting down the entire immune system.

Side effects

Common side effects:

  • Kidney function impairment
  • High blood pressure
  • Tremor and headache
  • Nausea and loss of appetite
  • Gum overgrowth (gingival hyperplasia)
  • Excessive hair growth
  • Muscle weakness or cramps
  • Increased risk of infections

Serious side effects requiring immediate medical attention:

Submit Your Paper
GMJ_Submit_Banner
  • Severe kidney damage or failure
  • Signs of serious infection (fever, persistent sore throat)
  • Symptoms of lymphoma or other cancers
  • Severe high blood pressure with headache or vision changes
  • Neurological symptoms including seizures or confusion

Warnings and precautions

  • Kidney monitoring required: Regular blood tests are essential as ciclosporin can cause significant kidney damage, particularly with long-term use or high doses
  • Increased cancer risk: Immunosuppression increases the risk of developing certain cancers, particularly skin cancers and lymphomas
  • Pregnancy considerations: Should only be used during pregnancy when benefits clearly outweigh risks; may cause low birth weight and premature delivery
  • Infection susceptibility: Patients are more vulnerable to bacterial, viral, and fungal infections due to suppressed immune function
  • Blood pressure monitoring: Can cause significant hypertension requiring regular monitoring and possible additional blood pressure medications

Interactions

  • Statins: Increased risk of muscle damage and kidney problems when combined with cholesterol-lowering medications
  • NSAIDs: Anti-inflammatory drugs like ibuprofen can increase kidney toxicity risk
  • Grapefruit juice: Significantly increases ciclosporin blood levels, potentially leading to toxicity
  • Antibiotics: Certain antibiotics like erythromycin can increase ciclosporin levels and toxicity risk
  • Antifungal medications: Drugs like ketoconazole can dramatically increase ciclosporin concentrations
  • St. John’s wort: This herbal supplement can reduce ciclosporin effectiveness by increasing its breakdown
  • ACE inhibitors: Blood pressure medications may increase kidney toxicity when combined with ciclosporin
  • Potassium supplements: May lead to dangerous potassium levels when used together

Check interactions with the GMJ Interaction Checker

Dosage

Dosing varies significantly based on the condition being treated, patient weight, and individual response. For organ transplantation, initial doses typically range from 10-15 mg/kg daily divided into two doses, then adjusted based on blood levels and kidney function. For autoimmune conditions, doses are generally lower, ranging from 2.5-5 mg/kg daily. Topical formulations for skin conditions are applied twice daily to affected areas. All dosing must be individualized and carefully monitored by healthcare providers through regular blood level testing and organ function assessment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Ciclosporin." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/ciclosporin/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Five Distinct Diabetes Development Patterns Identified Years Before Diagnosis

European study of 18,567 adults reveals five distinct metabolic pathways leading to…

Coeliac Disease Linked to Increased Death Risk and Cancer in Major US Study

Major US study of 60,000+ patients reveals coeliac disease patients face 39%…

Paralympic Doctor Returns to Sport as Blind Athlete with Guide Runner

Dr Oscar, a former Paralympic competitor turned medical professional, returns to sport…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Tacrolimus

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up